Brought to you by 
AlgoRx brings in $65mm with Series C round
17 Mar 2004
Executive Summary
Pain management company AlgoRx Pharmaceuticals raised $65mm through a Series C financing led by new investor Advent International. Returning backers InterWest Partners, JPMorgan Partners, and Sofinnova Ventures participated in the oversubscribed round along with additional new investors SR One, Pacific Rim Ventures, Index Ventures, Lehman Brothers Healthcare Fund, Hunt Ventures, EGS Healthcare Capital Partners, Piper Jaffray Ventures, NIF Ventures, Axiom Venture Partners, Cogene Biotech Ventures, and William Harris Investors.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AlgoRx brings in $65mm with Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice